NEW YORK, Aug. 25 (GenomeWeb News) - Jubilant Biosys of Bangalore, India, said today that it has used PathArt, a database of over 900 signaling and metabolic pathways that are manually curated from literature, to map Affymetrix Probeset IDs.
"PathArt ... includes wide coverage on disease-specific pathways such as several cancers, arthritis, Alzheimer's, asthma, multiple sclerosis, Parkinson's, diabetes, and atherosclerosis," Sreenivas Devidas, Jubilant's vice president of business development and strategy said in a statement. "Researchers can map the data generated from Affymetrix chips directly onto pathways."